PDCD1 and neoplasm: T cells express low levels of endogenous PD-L1, which leads to development of CAR-T cells that target PD-L1 is somewhat intricate by killing PD-L1-expressing tumor cells and blocking the PD-1/PD-L1 checkpoint axis.36